Announcements Trials
Browse Landscape

Phase

Phase NA 19Phase 2 7Phase 4 4Phase 3 3Phase 2/3 3

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 7

Sponsor

Cancer Type

Other 2Thoracic 1Plasma cell 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Stomatitis 2Mucositis 2Pain, Postoperative 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anastomotic Leak 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Water × Clear all
NCT05854589 2023-05-11

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

Batroussy, Rafik

Phase 2 Unknown
20 enrolled
Dermatologic

Melanoma

NCT04863248 2023-04-14

PRESERVE 4

G1 Therapeutics, Inc.

Phase 2 Terminated
10 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed
50 enrolled 9 charts
Other

Stomatitis, Mucositis

NCT02522598 2016-09-29

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy

Vivozon, Inc.

Phase 2 Completed
38 enrolled

Pain, Postoperative

NCT00970021 2014-02-25

Agaricus Blazei Murill in Patients With Multiple Myeloma

Oslo University Hospital

Phase 2 Completed
39 enrolled
Plasma cell

Multiple Myeloma

NCT00942526 2009-07-21

Oral Anti-Infective Agent for Esophageal Anastomotic Leakage

National Taiwan University Hospital

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡